2.
Forest plot of comparison: 2 Leukotriene Receptor Antagonists (LTRA) + ICS vs. DOUBLE dose of ICS in SYMPTOMATIC PATIENTS, outcome: 2.1 Patients with 1 or more exacerbations requiring systemic steroids at LICENSED DOSES.
Forest plot of comparison: 2 Leukotriene Receptor Antagonists (LTRA) + ICS vs. DOUBLE dose of ICS in SYMPTOMATIC PATIENTS, outcome: 2.1 Patients with 1 or more exacerbations requiring systemic steroids at LICENSED DOSES.